Skip to main content
. 2016 Jul 25;5:23. doi: 10.1186/s40169-016-0103-8

Fig. 2.

Fig. 2

Safety margin estimations: monoclonal antibodies. AUC area under the curve, C max maximum concentration, C semen seminal concentration, EFD embryo-fetal development, mAb monoclonal antibody, MABEL minimum anticipated biological effect level, NOAEL no adverse effect level